Tinea Versicolor: Clinical Trials

4 trials for Tinea Versicolor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Not yet recruiting 1, Recruiting 1
Phase 21Not yet recruiting 1

Follow Tinea Versicolor: new trials by email Literature Review of Tinea Versicolor trials Research Report on Tinea Versicolor

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor
Topical 1 % clotrimazole twice daily 2 weeks, Oral itraconazole 200mg daily for 5 days - Pityriasis Versicolor
Phase 1 / Phase 2Not yet recruitingCombined Military Hospital Abbottabad862026-02-022026-01-12
A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor
20% Cassia alata cream - Tinea Versicolor, Pityriasis Versicolor
Phase 1RecruitingThe University of The West Indies202025-03-012025-11-19
A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.
Ketoconazole Shampoo, 2%, Ketoconazole Shampoo, 2% (Reference Standard), Placebo - Tinea Versicolor
Phase 1CompletedSun Pharmaceutical Industries, Inc.4302023-12-042024-03-12
Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor
Fluconazole, Itraconazole - Tinea Versicolor
Phase 1CompletedCombined Military Hospital Abbottabad1642022-03-012023-05-17

Broader conditions

Bacterial Infections and Mycoses (4)  ·  Dermatomycoses (4)  ·  Infections (4)  ·  Mycoses (4)  ·  Skin Diseases (4)  ·  Skin Diseases, Infectious (4)  ·  Skin and Connective Tissue Diseases (4)

Interventions

Itraconazole (2)  ·  Fluconazole (1)  ·  Reference Standards (1)  ·  icon infiltrant (1)

Sponsors

Combined Military Hospital Abbottabad (2)  ·  Sun Pharmaceutical Industries, Inc. (1)  ·  The University of The West Indies (1)

Countries

Jamaica (1)  ·  Pakistan (1)  ·  United States (1)

Top investigators

Jonathan D Ho, MBBS, D.Sc (1)  ·  Natalie Yantovskiy (1)